Boston, MA, United States of America

Anjali Nath

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: The General Hospital Corporation, University of California. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anjali Nath: Innovator in Antidote Development

Introduction

Anjali Nath is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of medicine, particularly in the development of antidotes for cyanide poisoning. Her innovative work has the potential to save lives and improve treatment options for those affected by this toxic substance.

Latest Patents

Anjali Nath holds a patent for her groundbreaking work titled "Antidotes to cyanide poisoning." The patent describes a compound of Formula (I) or a pharmaceutically acceptable salt thereof, along with methods for using this compound to treat and prevent cyanide poisoning. This invention showcases her dedication to addressing critical health issues through scientific innovation.

Career Highlights

Throughout her career, Anjali has worked with esteemed organizations such as The General Hospital Corporation and the University of California. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Anjali has collaborated with notable colleagues, including Randall T. Peterson and Robert Gerszten. These partnerships have enriched her research and expanded the impact of her inventions in the medical community.

Conclusion

Anjali Nath's contributions to the development of antidotes for cyanide poisoning highlight her innovative spirit and commitment to improving public health. Her work exemplifies the vital role of inventors in advancing medical science and providing solutions to pressing health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…